In Poland, as in many parts of the world, a growing number of patients are being treated using biological or biosimilar drugs. The list of illnesses for which these drugs are prescribed includes psoriasis, Crohns disease, colitis, psoriatic and rheumatoid arthritis, ankylosing spondylitis and others. Consequently, the market has expanded recently to encompass new drugs and therapies designed to treat a growing variety of conditions and illnesses.
Browse Full Report With TOC: http://www.marketresearchreports.biz/analysis-details/biological-and-biosimilars-drug-market-in-poland-2013
Biologic and biosimilars drug market in Poland 2013, Development forecasts for 2013-2015 is a new PMR report designed to evaluate current market conditions and investigate the possibilities for growth and expansion in the coming years. From market size to research and development efforts of leading companies, this publication offers expert analysis of this market.
This document analyses the epidemiology fueling the growth of biologics in Poland, revealing the number of patients receiving these drugs. It analyses the reasons behind expansion and the potential obstacles that exist or will appear by 2015.
The competitive atmosphere of this segment of Polands pharmaceuticals market is carefully evaluated using profiles of the major Polish manufacturing companies active in this market that include financial condition updates, plans for upcoming additions to their product lines and plans to engage in new research and development activities. Recent entries into the Polish biologics market are examined along with the likelihood of M&A and consolidation activity in the next two years.
The expiration of various patents for biologic drugs is a timely market topic, and this publication highlights the businesses ready to capitalise on new developments. It reviews the mechanics of the market, offering explanation of the registration and refund procedures that apply to biologics in Poland and covering recent and upcoming regulatory changes and their likely impact on businesses supplying this market.
Table Of Content
I. Methodology 9
II. Executive summary 15
III. Market overview 19
IV. Results of the survey conducted among 35 companies operating on the market of biologicals and biosimilars in Poland 37
V. Biologicals in treatment of selected diseases in Poland 49
VI. Profiles of selected companies operating in the sector in Poland 97
VII. List of graphs 113
VIII. List of tables 117
IX. About PMR 119
To get Download Full Report With TOC on Discounted Price: http://www.marketresearchreports.biz/sample/sample/177022
About Us
Marketresearchreports.biz is the most comprehensive collection of market research reports. Marketresearchreports.biz services are especially designed to save time and money of our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.
Contact
M/s Sheela
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-997-4948
Email: sales@marketresearchreports.biz
Site: http://www.marketresearchreports.biz/
Browse Full Report With TOC: http://www.marketresearchreports.biz/analysis-details/biological-and-biosimilars-drug-market-in-poland-2013
Biologic and biosimilars drug market in Poland 2013, Development forecasts for 2013-2015 is a new PMR report designed to evaluate current market conditions and investigate the possibilities for growth and expansion in the coming years. From market size to research and development efforts of leading companies, this publication offers expert analysis of this market.
This document analyses the epidemiology fueling the growth of biologics in Poland, revealing the number of patients receiving these drugs. It analyses the reasons behind expansion and the potential obstacles that exist or will appear by 2015.
The competitive atmosphere of this segment of Polands pharmaceuticals market is carefully evaluated using profiles of the major Polish manufacturing companies active in this market that include financial condition updates, plans for upcoming additions to their product lines and plans to engage in new research and development activities. Recent entries into the Polish biologics market are examined along with the likelihood of M&A and consolidation activity in the next two years.
The expiration of various patents for biologic drugs is a timely market topic, and this publication highlights the businesses ready to capitalise on new developments. It reviews the mechanics of the market, offering explanation of the registration and refund procedures that apply to biologics in Poland and covering recent and upcoming regulatory changes and their likely impact on businesses supplying this market.
Table Of Content
I. Methodology 9
II. Executive summary 15
III. Market overview 19
IV. Results of the survey conducted among 35 companies operating on the market of biologicals and biosimilars in Poland 37
V. Biologicals in treatment of selected diseases in Poland 49
VI. Profiles of selected companies operating in the sector in Poland 97
VII. List of graphs 113
VIII. List of tables 117
IX. About PMR 119
To get Download Full Report With TOC on Discounted Price: http://www.marketresearchreports.biz/sample/sample/177022
About Us
Marketresearchreports.biz is the most comprehensive collection of market research reports. Marketresearchreports.biz services are especially designed to save time and money of our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.
Contact
M/s Sheela
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-997-4948
Email: sales@marketresearchreports.biz
Site: http://www.marketresearchreports.biz/
0 comments:
Post a Comment